Immunosuppression by ultraviolet B radiation: initiation by urocanic acid.

F. Noonan,E. Fabo

DOI: https://doi.org/10.1016/0167-5699(92)90005-R

Abstract:

What problem does this paper attempt to address?

Classification and Molecular Functions of Heparan Sulfate Proteoglycans and Their Molecular Mechanisms with the Receptor

Yasunari Matsuzaka,Ryu Yashiro

DOI: https://doi.org/10.3390/biologics4020008

2024-03-28

Biologics

Abstract:Heparan sulfate proteoglycans are highly glycosylated proteins in which heparan sulfate, a glycosaminoglycan sugar chain, is an acidic sugar chain consisting of a repeating disaccharide structure of glucuronic acid and N-acetylglucosamine is locally sulfated. Syndecan, one of the transmembrane HSPGs, functions as a receptor that transmits signals from the extracellular microenvironment to the inside of the cell. In the vascular system, heparan sulfate proteoglycans, a major component of the glycocalyx, enable the binding of various plasma-derived molecules due to their diversity, epimerization of glycosaminoglycans chains, long chains, and sulfation. Heparan sulfate proteoglycans present in the extracellular matrix serve as a reservoir for bioactive molecules such as chemokines, cytokines, and growth factors. Aberrant expression of heparan sulfate proteoglycans, heparanase, and sulfatase is observed in many pathological conditions. Therefore, it can be applied to therapeutic strategies for a wide range of fields including Alzheimer’s disease, heart failure, cancer, organ transplants, diabetes, chronic inflammation, aging, and autoimmune diseases.
Sclerosed hemangioma of the liver

H. Aibe,H. Honda,T. Kuroiwa,K. Yoshimitsu,H. Irie,T. Tajima,K. Shinozaki,Y. Asayama,K. Taguchi,K. Masuda

DOI: https://doi.org/10.1007/s002610000202

2001-09-01

Abdominal Imaging

Abstract:
Heparan sulfate proteoglycans in pathological protein aggregation and brain functionality

James Melrose,Margaret M. Smith

DOI: https://doi.org/10.36922/an.3812

2024-08-28

Advanced Neurology

Abstract:Proteoglycans are highly specialized proteins with specific interactive modules in their core proteins, allowing them to engage with a diverse range of cellular and structural proteins, contributing to many varied roles in cell processes. This review examines the roles of heparan sulfate (HS) proteoglycans (HSPGs) in the assembly of pathological protein aggregates in brain tissues, which negatively impact cognitive brain function. While HSPGs play roles in normal brain development, they also contribute to the abnormal accumulation and persistence of protein aggregates in Alzheimer’s and Parkinson’s diseases (AD and PD), prolonging their neurotoxic effects. HSPG-mediated effects on the innate immune system may also contribute to the development of neuroinflammation and pathogenesis of neurodegenerative changes in the central nervous system. These pathological developments lead to impaired cognition, permanent memory loss in dementia and AD, and an inability of the brain to exert normal neuromuscular control, affecting motor functions and body movement in PD. A deeper understanding of the properties of HS in these degenerative processes is essential for the development of therapeutic measures to treat these conditions. Significant improvements in neuroimaging, next-generation glycosaminoglycan analytical techniques, and functional glycomics hold great promise for elucidating the complexities of HS structure and function. These advancements may significantly aid in the development of HS biotherapeutics to treat these debilitating conditions, which are increasingly impacting the aging global population. While a number of promising therapeutic candidates have already emerged, further research is required to optimize their biotherapeutic applications in this challenging area of pathobiology, bioregulation, and the recovery of neural function.
A biological guide to glycosaminoglycans: current perspectives and pending questions

Sylvie Ricard‐Blum,Romain R. Vivès,Liliana Schaefer,Martin Götte,Rosetta Merline,Alberto Passi,Paraskevi Heldin,Ana Magalhães,Celso A. Reis,Spyros S. Skandalis,Nikos K. Karamanos,Serge Perez,Dragana Nikitovic

DOI: https://doi.org/10.1111/febs.17107

2024-03-20

FEBS Journal

Abstract:Mammalian glycosaminoglycans, except hyaluronan, are sulfated polysaccharides that are covalently attached to core proteins to form proteoglycans. They contribute to the organization of the extracellular matrix and are displayed at the cell surface where they regulate the availability and activity of cytokines and growth factors and cell signaling. Their biosynthesis is altered in cancer, inflammation, and fibrosis, making them potential biomarkers of these diseases. Mammalian glycosaminoglycans (GAGs), except hyaluronan (HA), are sulfated polysaccharides that are covalently attached to core proteins to form proteoglycans (PGs). This article summarizes key biological findings for the most widespread GAGs, namely HA, chondroitin sulfate/dermatan sulfate (CS/DS), keratan sulfate (KS), and heparan sulfate (HS). It focuses on the major processes that remain to be deciphered to get a comprehensive view of the mechanisms mediating GAG biological functions. They include the regulation of GAG biosynthesis and postsynthetic modifications in heparin (HP) and HS, the composition, heterogeneity, and function of the tetrasaccharide linkage region and its role in disease, the functional characterization of the new PGs recently identified by glycoproteomics, the selectivity of interactions mediated by GAG chains, the display of GAG chains and PGs at the cell surface and their impact on the availability and activity of soluble ligands, and on their move through the glycocalyx layer to reach their receptors, the human GAG profile in health and disease, the roles of GAGs and particular PGs (syndecans, decorin, and biglycan) involved in cancer, inflammation, and fibrosis, the possible use of GAGs and PGs as disease biomarkers, and the design of inhibitors targeting GAG biosynthetic enzymes and GAG–protein interactions to develop novel therapeutic approaches.

biochemistry & molecular biology
Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis

Richard T. Piszczatowski,Hannes Buelow,Ulrich Steidl

DOI: https://doi.org/10.1182/blood.2023022736

IF: 20.3

2024-04-21

Blood

Abstract:From signaling mediators in stem cells, to markers of differentiation and lineage commitment, to facilitators for the entry of viruses like HIV-1, cell surface heparan sulfate (HS) glycans with their distinct modification patterns play important roles in hematopoietic biology. In this review, we provide an overview of the importance of HS and the proteoglycans (HSPGs) to which they are attached, within the major cellular subtypes of the hematopoietic system. We summarize the roles of HSPGs, HS, and HS modifications within each main hematopoietic cell lineage of both myeloid and lymphoid arms. Lastly, we discuss the biological advances of the detection of HS modifications, and their potential to further discriminate cell types within hematopoietic tissue.

hematology
Biological role of heparan sulfate in osteogenesis: A review

Zhujie Xu,Shayang Chen,Dehong Feng,Yi Liu,Qiqi Wang,Tianshu Gao,Zhenwei Liu,Yan Zhang,Jinghua Chen,Lipeng Qiu

DOI: https://doi.org/10.1016/j.carbpol.2021.118490

IF: 10.723

2021-11-01

Carbohydrate Polymers

Abstract:Heparan sulfate (HS) is extensively expressed in cells, for example, cell membrane and extracellular matrix of most mammalian cells and tissues, playing a key role in the growth and development of life by maintaining homeostasis and implicating in the etiology and diseases. Recent studies have revealed that HS is involved in osteogenesis via coordinating multiple signaling pathways. The potential effect of HS on osteogenesis is a complicated and delicate biological process, which involves the participation of osteocytes, chondrocytes, osteoblasts, osteoclasts and a variety of cytokines. In this review, we summarized the structural and functional characteristics of HS and highlighted the molecular mechanism of HS in bone metabolism to provide novel research perspectives for the further medical research.

polymer science,chemistry, organic, applied
Interactions of proteins with heparan sulfate

Faizah S Alotaibi,Marim M R Alsadun,Sarah A Alsaiari,Krithika Ramakrishnan,Edwin A Yates,David G Fernig

DOI: https://doi.org/10.1042/ebc20230093

2024-04-23

Essays in Biochemistry

Abstract:Heparan sulfate (HS) is a glycosaminoglycan, polysaccharides that are considered to have arisen in the last common unicellular ancestor of multicellular animals. In this light, the large interactome of HS and its myriad functions in relation to the regulation of cell communication are not surprising. The binding of proteins to HS determines their localisation and diffusion, essential for embryonic development and homeostasis. Following the biosynthesis of the initial heparosan polymer, the...

biochemistry & molecular biology
Ecophysiology of environmental Aspergillus fumigatus and comparison with clinical strains on gliotoxin production and elastase activity

V. Alonso,C. Aminahuel,L. D. Díaz Vergara,C. Pereyra,V. Poloni,A. Dalcero,L. Cavaglieri

DOI: https://doi.org/10.1111/lam.12523

2016-02-01

Letters in Applied Microbiology

Abstract:The aim of this manuscript was to study the influence of water activity (aW) and pH in the ecophysiological behaviour of Aspergillus fumigatus strains at human body temperature. In addition, gliotoxin production and enzymatic ability among environmental (n = 2) and clinical (n = 5) strains were compared. Ecophysiological study of environmental strains was performed on agar silage incubated at 37°C, studying the interaction at eight aW levels (0·8, 0·85, 0·9, 0·92, 0·94, 0·96, 0·98 and 0·99) and eight pH levels (3·5, 4, 4·5, 5, 6, 7, 7·5 and 8). Considering the influence of the assumed lung conditions on growth of A. fumigatus (aW 0·98/0·99 and pH of 7/7·5), the optimal condition for the development of A. fumigatus RC031 was at aW 0·99 at pH 7. At aW 0·98/0·99 and pH of 7/7·5, the highest growth rate and the lowest lag phase was reported, whereas there were no significant differences at aW 0·98/0·99 and pH 7/7·5 interactions on growth of A. fumigatus RC032. Gliotoxin production of A. fumigatus strains was evaluated. The gliotoxin production was similar in clinical and environmental strains. Elastin activity was studied in solid medium, highest elastase activity index was found for clinical strain A. fumigatus RC0676, followed by the environmental strain A. fumigatus RC031. Opportunistic environmental strains can be considered as pathogenic in some cases when rural workers are exposed constantly to handling silage.
Heparan sulfate functions are altered in the osteoarthritic cartilage

Sara Shamdani,Sandrine Chantepie,Camille Flageollet,Nadia Henni-Chebra,Yohann Jouan,Florent Eymard,Eric Hay,Martine Cohen-Solal,Dulce Papy-Garcia,Xavier Chevalier,Patricia Albanese

DOI: https://doi.org/10.1186/s13075-020-02352-3

2020-12-07

Abstract:Background: Heparan sulfate (HS) proteoglycans (PG) may be found at the chondrocyte surface and in the pericellular cartilage matrix, and are involved in cell-cell and cell-matrix interactions. An important function of HS chains is to regulate cell fate through specific interactions with heparin-binding proteins (HBP) modulated by their complex sulfation pattern. Osteoarthritis (OA) is a joint disorder characterized by the degradation of articular cartilaginous extracellular matrix. The aim of this study was to investigate HS structure and functions in osteoarthritic cartilages compared to normal cartilages (controls). Methods: Glycosaminoglycans (GAG) were extracted from human macroscopically normal cartilages (controls, n = 7) and (OA cartilages n = 11). HS were isolated and quantified using the DMMB quantification method. Their structure and functions were then compared using respectively a HPLC analysis and HBP binding tests and their phenotypic effects on murine chondrocytes were studied by RQ-PCR. Statistical analyzes were performed using a one-way ANOVA followed by a Dunnett's test or a t test for pairwise comparisons. Results: In OA, HS were characterized by increased sulfation levels compared to controls. Moreover, the capacity of these HS to bind HBP involved in the OA pathophysiological process such as FGF2 and VEGF was reduced. Chondroitin sulfates and keratan sulfates regulated these binding properties. Finally, HS from OA cartilages induced the mRNA levels of catabolic markers such as MMP3, MMP13, and TS4 and inhibited the mRNA levels of anabolic markers such as COL2, ACAN, SOX9, and VEGF in murine articular chondrocytes. Conclusion: The sulfation of HS chains was increased in OA cartilages with changes in HBP binding properties and biological effects on chondrocyte phenotypes. Thus, modified HS present in altered cartilages could be a novel therapeutic target in OA.
Heparan sulfates and heparan sulfate binding proteins in sepsis

Yi-En Liao,Jian Liu,Katelyn Arnold

DOI: https://doi.org/10.3389/fmolb.2023.1146685

2023-02-14

Abstract:Heparan sulfates (HSs) are the main components in the glycocalyx which covers endothelial cells and modulates vascular homeostasis through interactions with multiple Heparan sulfate binding proteins (HSBPs). During sepsis, heparanase increases and induces HS shedding. The process causes glycocalyx degradation, exacerbating inflammation and coagulation in sepsis. The circulating heparan sulfate fragments may serve as a host defense system by neutralizing dysregulated Heparan sulfate binding proteins or pro-inflammatory molecules in certain circumstances. Understanding heparan sulfates and heparan sulfate binding proteins in health and sepsis is critical to decipher the dysregulated host response in sepsis and advance drug development. In this review, we will overview the current understanding of HS in glycocalyx under septic condition and the dysfunctional heparan sulfate binding proteins as potential drug targets, particularly, high mobility group box 1 (HMGB1) and histones. Moreover, several drug candidates based on heparan sulfates or related to heparan sulfates, such as heparanase inhibitors or heparin-binding protein (HBP), will be discussed regarding their recent advances. By applying chemical or chemoenzymatic approaches, the structure-function relationship between heparan sulfates and heparan sulfate binding proteins is recently revealed with structurally defined heparan sulfates. Such homogenous heparan sulfates may further facilitate the investigation of the role of heparan sulfates in sepsis and the development of carbohydrate-based therapy.
Investigation of the biological functions of heparan sulfate using a chemoenzymatic synthetic approach

Zhangjie Wang,Katelyn Arnold,Vijay Manohar Dhurandhare,Yongmei Xu,Jian Liu

DOI: https://doi.org/10.1039/d0cb00199f

2021-01-01

RSC Chemical Biology

Abstract:Heparan sulfate (HS) is a highly sulfated polysaccharide playing essential physiological and pathophysiological roles in the animal kingdom.
Heparan sulfate and heparin interactions with proteins

Maria C. Z. Meneghetti,Ashley J. Hughes,Timothy R. Rudd,Helena B. Nader,Andrew K. Powell,Edwin A. Yates,Marcelo A. Lima

DOI: https://doi.org/10.1098/rsif.2015.0589

IF: 4.293

2015-09-01

Journal of The Royal Society Interface

Abstract:Heparan sulfate (HS) polysaccharides are ubiquitous components of the cell surface and extracellular matrix of all multicellular animals, whereas heparin is present within mast cells and can be viewed as a more sulfated, tissue-specific, HS variant. HS and heparin regulate biological processes through interactions with a large repertoire of proteins. Owing to these interactions and diverse effects observed during in vitro , ex vivo and in vivo experiments, manifold biological/pharmacological activities have been attributed to them. The properties that have been thought to bestow protein binding and biological activity upon HS and heparin vary from high levels of sequence specificity to a dependence on charge. In contrast to these opposing opinions, we will argue that the evidence supports both a level of redundancy and a degree of selectivity in the structure–activity relationship. The relationship between this apparent redundancy, the multi-dentate nature of heparin and HS polysaccharide chains, their involvement in protein networks and the multiple binding sites on proteins, each possessing different properties, will also be considered. Finally, the role of cations in modulating HS/heparin activity will be reviewed and some of the implications for structure–activity relationships and regulation will be discussed.

multidisciplinary sciences
Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharides

Marissa L. Maciej-Hulme,Jandi Kim,Elijah T. Roberts,Yiqing Zhang,Anouk van der Velden,Dirk den Braanker,Cansu Yanginlar,Mark de Graaf,Ton Rabelink,Bernard van den Berg,Ellen van Omen,Rutger Maas,Anne-Els van de Logt,I. Jonathan Amster,Johan van der Vlag

DOI: https://doi.org/10.1101/2024.09.18.613784

2024-09-19

Abstract:Heparan sulfates (HS) are a group of heterogenous linear, sulfated polysaccharides that play a role in in health and many diseases including cancer, cardiovascular, and kidney diseases. The structural variety of HS has greatly challenged the development and utility of HS analytics, particularly for native structures, leaving a significant gap in HS technologies for clinical application. Mass spectrometry (MS)-based profiling with bioinformatics offers a top-down approach that can retain variety in large data sets. Using healthy human plasmas, we developed an MS glycoprofiling approach for native HS oligosaccharides, which retains the structural complexity of each individual HS chain and generates an HS ‘index’ (or Heparan-ome) for each patient. As a proof of concept, analysis of 56 plasma samples ranging from 6 groups of kidney disease patients revealed a new subset cluster (20%, 4/20) of membranous glomerulopathy (MG) patients with distinct HS profiles, highlighting the potential of HS glycoprofiling as a powerful new approach into clinical practice, which warrants future development into clinical diagnostics of kidney and other diseases.

Bioinformatics
A Systems View of the Heparan Sulfate Interactome

Alejandro Gómez Toledo,James T. Sorrentino,Daniel R. Sandoval,Johan Malmström,Nathan E. Lewis,Jeffrey D. Esko

DOI: https://doi.org/10.1369/0022155420988661

2021-01-26

Abstract:Heparan sulfate proteoglycans consist of a small family of proteins decorated with one or more covalently attached heparan sulfate glycosaminoglycan chains. These chains have intricate structural patterns based on the position of sulfate groups and uronic acid epimers, which dictate their ability to engage a large repertoire of heparan sulfate–binding proteins, including extracellular matrix proteins, growth factors and morphogens, cytokines and chemokines, apolipoproteins and lipases, adhesion and growth factor receptors, and components of the complement and coagulation system. This review highlights recent progress in the characterization of the so-called “heparan sulfate interactome,” with a major focus on systems-wide strategies as a tool for discovery and characterization of this subproteome. In addition, we compiled all heparan sulfate–binding proteins reported in the literature to date and grouped them into a few major functional classes by applying a networking approach.

cell biology
Functions of Heparan Sulfate Proteoglycans in Cell Signaling During Development

Xinhua Lin

DOI: https://doi.org/10.1242/dev.01522

IF: 6.8622

2004-01-01

Development

Abstract:Heparan sulfate proteoglycans (HSPGs) are cell-surface and extracellular matrix macromolecules that are composed of a core protein decorated with covalently linked glycosaminoglycan (GAG) chains. In vitro studies have demonstrated the roles of these molecules in many cellular functions, and recent in vivo studies have begun to clarify their essential functions in development. In particular, HSPGs play crucial roles in regulating key developmental signaling pathways, such as the Wnt, Hedgehog, transforming growth factor-β, and fibroblast growth factor pathways. This review highlights recent findings regarding the functions of HSPGs in these signaling pathways during development.
Bioactive synthetic heparan sulfate and heparin derivatives: From long fragments mimetics to chimeras

David Bonnaffé

DOI: https://doi.org/10.1016/j.crci.2010.06.002

2011-01-01

Comptes Rendus Chimie

Abstract:Heparan sulfate (HS) and heparin (HP) belong to the glycosaminoglycan (GAG) family, which are linear and sulfated polysaccharides. Several levels of molecular diversity allow these polymers to display one of the highest information content amongst all biopolymers and to bind and regulate, often in a specific way, the activity of numerous proteins. After analysing the structural basis of HS and HP molecular diversity, we will describe how chemists are able to exploit several of these features to produce compounds with exquisite tailor-made bioactivities and optimised pharmacological profiles, leading to promising drug candidates in preclinical or clinical studies and approved treatments.

chemistry, multidisciplinary
The 3- O-sulfation of heparan sulfate modulates protein binding and lyase degradation

Pradeep Chopra,Apoorva Joshi,Jiandong Wu,Weigang Lu,Tejabhiram Yadavalli,Margreet A Wolfert,Deepak Shukla,Joseph Zaia,Geert-Jan Boons

DOI: https://doi.org/10.1073/pnas.2012935118

2021-01-19

Abstract:Humans express seven heparan sulfate (HS) 3-O-sulfotransferases that differ in substrate specificity and tissue expression. Although genetic studies have indicated that 3-O-sulfated HS modulates many biological processes, ligand requirements for proteins engaging with HS modified by 3-O-sulfate (3-OS) have been difficult to determine. In particular, the context in which the 3-OS group needs to be presented for binding is largely unknown. We describe herein a modular synthetic approach that can provide structurally diverse HS oligosaccharides with and without 3-OS. The methodology was employed to prepare 27 hexasaccharides that were printed as a glycan microarray to examine ligand requirements of a wide range of HS-binding proteins. The binding selectivity of antithrombin-III (AT-III) compared well with anti-Factor Xa activity supporting robustness of the array technology. Many of the other examined HS-binding proteins required an IdoA2S-GlcNS3S6S sequon for binding but exhibited variable dependence for the 2-OS and 6-OS moieties, and a GlcA or IdoA2S residue neighboring the central GlcNS3S. The HS oligosaccharides were also examined as inhibitors of cell entry by herpes simplex virus type 1, which, surprisingly, showed a lack of dependence of 3-OS, indicating that, instead of glycoprotein D (gD), they competitively bind to gB and gC. The compounds were also used to examine substrate specificities of heparin lyases, which are enzymes used for depolymerization of HS/heparin for sequence determination and production of therapeutic heparins. It was found that cleavage by lyase II is influenced by 3-OS, while digestion by lyase I is only affected by 2-OS. Lyase III exhibited sensitivity to both 3-OS and 2-OS.
Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides

Rebecca L. Miller,Scott E. Guimond,Ralf Schwörer,Olga V. Zubkova,Peter C. Tyler,Yongmei Xu,Jian Liu,Pradeep Chopra,Geert-Jan Boons,Márkó Grabarics,Christian Manz,Johanna Hofmann,Niclas G. Karlsson,Jeremy E. Turnbull,Weston B. Struwe,Kevin Pagel

DOI: https://doi.org/10.1038/s41467-020-15284-y

IF: 16.6

2020-03-20

Nature Communications

Abstract:Abstract Despite evident regulatory roles of heparan sulfate (HS) saccharides in numerous biological processes, definitive information on the bioactive sequences of these polymers is lacking, with only a handful of natural structures sequenced to date. Here, we develop a “ S hotgun” I on M obility M ass S pectrometry S equencing (SIMMS 2 ) method in which intact HS saccharides are dissociated in an ion mobility mass spectrometer and collision cross section values of fragments measured. Matching of data for intact and fragment ions against known values for 36 fully defined HS saccharide structures (from di- to decasaccharides) permits unambiguous sequence determination of validated standards and unknown natural saccharides, notably including variants with 3 O -sulfate groups. SIMMS 2 analysis of two fibroblast growth factor-inhibiting hexasaccharides identified from a HS oligosaccharide library screen demonstrates that the approach allows elucidation of structure-activity relationships. SIMMS 2 thus overcomes the bottleneck for decoding the informational content of functional HS motifs which is crucial for their future biomedical exploitation.

multidisciplinary sciences
Structural analysis of synthetic heparan sulfate oligosaccharides with fibroblast growth factors and heparin-binding hemagglutinin

Medel Manuel L Zulueta,Chia-Lin Chyan,Shang-Cheng Hung

DOI: https://doi.org/10.1016/j.sbi.2018.03.003

Abstract:Heparan sulfate interacts with a variety of proteins at the cell surface. These proteins are primarily attracted to the high negative charge distribution brought by sulfate, sulfamate, and carboxylate functionalities along the sugar chain. Apart from electrostatic interactions, hydrogen bonding and even hydrophobic interactions contribute to the complex formation. While additional sulfate/sulfamate groups are often tolerated as long as the main structural requirements are met, occasionally, certain extra sulfate groups may be detrimental to the binding affinity. Here, we show these binding characteristics using the binding of fibroblast growth factors and heparin-binding hemagglutinin to synthetic heparan sulfate oligosaccharides as examples. Insights into the binding characteristics of these proteins may benefit future therapeutic interventions.
Role of arterial wall properties in the pathogenesis of systolic hypertension.

G. London

DOI: https://doi.org/10.1016/J.AMJHYPER.2004.10.001

American Journal of Hypertension

Abstract:

Immunosuppression by ultraviolet B radiation: initiation by urocanic acid.

Classification and Molecular Functions of Heparan Sulfate Proteoglycans and Their Molecular Mechanisms with the Receptor

Sclerosed hemangioma of the liver

Heparan sulfate proteoglycans in pathological protein aggregation and brain functionality

A biological guide to glycosaminoglycans: current perspectives and pending questions

Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis

Biological role of heparan sulfate in osteogenesis: A review

Interactions of proteins with heparan sulfate

Ecophysiology of environmental Aspergillus fumigatus and comparison with clinical strains on gliotoxin production and elastase activity

Heparan sulfate functions are altered in the osteoarthritic cartilage

Heparan sulfates and heparan sulfate binding proteins in sepsis

Investigation of the biological functions of heparan sulfate using a chemoenzymatic synthetic approach

Heparan sulfate and heparin interactions with proteins

Glycoinformatic profiling of label-free intact heparan sulfate oligosaccharides

A Systems View of the Heparan Sulfate Interactome

Functions of Heparan Sulfate Proteoglycans in Cell Signaling During Development

Bioactive synthetic heparan sulfate and heparin derivatives: From long fragments mimetics to chimeras

The 3- O-sulfation of heparan sulfate modulates protein binding and lyase degradation

Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides

Structural analysis of synthetic heparan sulfate oligosaccharides with fibroblast growth factors and heparin-binding hemagglutinin

Role of arterial wall properties in the pathogenesis of systolic hypertension.